- Home
- CHEF vs CNTA Comparison
CHEF vs CNTA Comparison
Compare CHEF & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEF
- CNTA
- Stock Information
- Founded
- CHEF 1985
- CNTA 2020
- Country
- CHEF United States
- CNTA United Kingdom
- Employees
- CHEF N/A
- CNTA N/A
- Industry
- CHEF Food Distributors
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- CHEF Consumer Discretionary
- CNTA Health Care
- Exchange
- CHEF Nasdaq
- CNTA Nasdaq
- Market Cap
- CHEF 2.2B
- CNTA 2.2B
- IPO Year
- CHEF 2011
- CNTA 2021
- Fundamental
- Price
- CHEF $52.70
- CNTA $16.47
- Analyst Decision
- CHEF Strong Buy
- CNTA Strong Buy
- Analyst Count
- CHEF 6
- CNTA 8
- Target Price
- CHEF $66.00
- CNTA $23.17
- AVG Volume (30 Days)
- CHEF 722.2K
- CNTA 1.0M
- Earning Date
- CHEF 04-30-2025
- CNTA 03-27-2025
- Dividend Yield
- CHEF N/A
- CNTA N/A
- EPS Growth
- CHEF 50.69
- CNTA N/A
- EPS
- CHEF 1.32
- CNTA N/A
- Revenue
- CHEF $3,794,212,000.00
- CNTA $6,853,000.00
- Revenue This Year
- CHEF $7.95
- CNTA N/A
- Revenue Next Year
- CHEF $7.37
- CNTA N/A
- P/E Ratio
- CHEF $40.05
- CNTA N/A
- Revenue Growth
- CHEF 10.50
- CNTA N/A
- 52 Week Low
- CHEF $31.96
- CNTA $7.75
- 52 Week High
- CHEF $66.51
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- CHEF 31.58
- CNTA 50.60
- Support Level
- CHEF $60.55
- CNTA $15.30
- Resistance Level
- CHEF $62.85
- CNTA $17.29
- Average True Range (ATR)
- CHEF 2.39
- CNTA 1.14
- MACD
- CHEF -1.59
- CNTA 0.03
- Stochastic Oscillator
- CHEF 5.50
- CNTA 69.29
About CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. The Chefs' Warehouse operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, mid and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos and speciality food stores.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.